首页> 外文OA文献 >Effects of 25-Hydroxyvitamin D3 on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1α-Hydroxylase
【2h】

Effects of 25-Hydroxyvitamin D3 on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1α-Hydroxylase

机译:25-羟维生素D3对需要CYP27B1 /1α-羟化酶的骨髓基质细胞增殖和成骨细胞分化的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1,25-Dihydroxyvitamin D3 [1,25(OH)2D3] has many noncalcemic actions that rest on inhibition of proliferation and promotion of differentiation in malignant and normal cell types. 1,25(OH)2D3 stimulates osteoblast differentiation of human marrow stromal cells (hMSCs), but little is known about the effects of 25-hydroxyvitamin D3 [25(OH)D3] on these cells. Recent evidence shows that hMSCs participate in vitamin D metabolism and can activate 25(OH)D3 by CYP27B1/1α-hydroxylase. These studies test the hypothesis that antiproliferative and prodifferentiation effects of 25(OH)D3 in hMSCs depend on CYP27B1. We studied hMSCs that constitutively express high (hMSCshi-1α) or low (hMSCslo-1α) levels of CYP27B1 with equivalent expression of CYP24A1 and vitamin D receptor. In hMSCshi-1α, 25(OH)D3 reduced proliferation, downregulated proliferating cell nuclear antigen (PCNA), upregulated p21Waf1/Cip1, and decreased cyclin D1. Unlike 1,25(OH)2D3, the antiapoptotic effects of 25(OH)D3 on Bax and Bcl-2 were blocked by the P450 inhibitor ketoconazole. The antiproliferative effects of 25(OH)D3 in hMSCshi-1α and of 1,25(OH)2D3 in both samples of hMSCs were explained by cell cycle arrest, not by increased apoptosis. Stimulation of osteoblast differentiation in hMSCshi-1α by 25(OH)D3 was prevented by ketoconazole and upon transfection with CYP27B1 siRNA. These data indicate that CYP27B1 is required for 25(OH)D3's action in hMSCs. Three lines of evidence indicate that CYP27B1 is required for the antiproliferative and prodifferentiation effects of 25(OH)D3 on hMSCs: Those effects were not seen (1) in hMSCs with low constitutive expression of CYP27B1, (2) in hMSCs treated with ketoconazole, and (3) in hMSCs in which CYP27B1 expression was silenced. Osteoblast differentiation and skeletal homeostasis may be regulated by autocrine/paracrine actions of 25(OH)D3 in hMSCs. © 2011 American Society for Bone and Mineral Research.
机译:1,25-二羟基维生素D3 [1,25(OH)2D3]具有许多非钙化作用,其作用在于抑制恶性和正常细胞类型的增殖和促进分化。 1,25(OH)2D3刺激人骨髓基质细胞(hMSCs)的成骨细胞分化,但对25-羟基维生素D3 [25(OH)D3]对这些细胞的作用所知甚少。最近的证据表明,hMSCs参与维生素D代谢并可以通过CYP27B1 /1α-羟化酶激活25(OH)D3。这些研究检验了25(OH)D3在hMSC中的抗增殖和分化作用依赖于CYP27B1的假说。我们研究了组成型表达高水平(hMSCshi-1α)或低水平(hMSCslo-1α)的CYP27B1与同等表达CYP24A1和维生素D受体的hMSC。在hMSCshi-1α中,25(OH)D3减少增殖,下调增殖细胞核抗原(PCNA),上调p21Waf1 / Cip1,并降低细胞周期蛋白D1。与1,25(OH)2D3不同,P450抑制剂酮康唑阻断了25(OH)D3对Bax和Bcl-2的抗凋亡作用。 hMSCshi-1α中25(OH)D3和hMSCs两种样品中1,25(OH)2D3的抗增殖作用都是通过细胞周期阻滞而不是通过增加细胞凋亡来解释的。酮康唑和用CYP27B1 siRNA转染可防止25(OH)D3刺激hMSCshi-1α中的成骨细胞分化。这些数据表明CYP27B1是hMSCs中25(OH)D3的作用所必需的。三行证据表明CYP27B1是25(OH)D3对hMSC的抗增殖和分化作用所必需的:未观察到这些作用(1)在CYP27B1组成型表达低的hMSC中,(2)在用酮康唑处理的hMSC中, (3)在CYP27B1表达沉默的hMSC中。成骨细胞的分化和骨骼的稳态可能受到hMSCs中25(OH)D3的自分泌/旁分泌作用的调节。 ©2011美国骨骼和矿物质研究学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号